Raltegravir plus abacavir/lamivudine in virologically suppressed HIV-1-infected patients: 48-week results of the KIRAL study

1. Troya, J.
2. Montejano, R.
3. Ryan, P.
4. Gómez, C.
5. Matarranz, M.
6. Cabello, A.
7. Vera, F.
8. Sepúlveda, M.A.
9. Santos, I.
10. Samperiz, G.
11. Bachiller, P.
12. Boix, V.
13. Barrufet, P.
14. Cervero, M.
15. Sanz, J.
16. Solís, J.
17. Yllescas, M.
18. Valencia, E.